Christian Itin, Autolus CEO (UKBIO19)

BioN­Tech, Au­to­lus strike wide-rang­ing li­cens­ing and man­u­fac­tur­ing deal for CAR-T ther­a­pies

BioN­Tech is en­list­ing CAR-T biotech Au­to­lus Ther­a­peu­tics on a part­ner­ship aimed at push­ing both of their CAR-T pro­grams to­ward com­mer­cial­iza­tion, with an eye on its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.